Although Merck (NYSE:MRK) is confronted with the unavoidable Keytruda patent cliff in 2028, the company is strategically positioning itself for further growth by diversifying and expanding its ...

US pharmaceutical firm Merck & Co plans to build a £1 billion “hub” opposite London’s King’s Cross station, according to press reports. The company known as MSD outside of North America ...

The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...

LONDON, June 6, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, announced the winners of the 2025 Prix Galien UK ...

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre-term ...

Specifically, SK Life Science is leveraging Axtria’s sales planning and operations solution, Axtria SalesIQ, to support an industry-leading, effective, and motivated sales team.

About This EventCaris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square.In honor of the ...

German science and technology company Merck on Thursday forecast its net sales to be in the range of €21.5 billion ($23.2 billion) and €22.9 billion in 2025. It also projects its adjusted ...

Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that it has launched the roadshow for its proposed ...

Recognising the Changemakers Driving Sustainable Business Forward LONDON, June 18, 2025 /PRNewswire/ -- BizClik, the global B2B digital media and events company, is proud to announce the ...